DRMAW vs TTWO
Dermata Therapeutics Inc. Warrant (DRMAW) versus Take-Two Interactive Software Inc (TTWO) — a side-by-side from cached financials, not a winner call.
Dermata Therapeutics Inc. Warrant (DRMAW) common stock listed on NASDAQ.
Take-Two Interactive Software Inc (TTWO) is a electronic gaming & multimedia company listed on NASDAQ.
DRMAW does not have a complete income-statement cache yet.
Latest reported TTWO revenue for 2026-03-31 was $6.66B. Net income was -$298.2M. Revenue was up 18.2% from 2025-03-31 to 2026-03-31. TTWO currently screens at market cap $42.34B.
DRMAW currently screens at market cap $0. TTWO currently screens at market cap $42.34B.
Not investment advice. Open the DRMAW and TTWO stock pages for the full models.
Not investment advice.